These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7784092

  • 21. A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease.
    Dvoráková S, Dvoráková K, Malíková M, Skába R, Vlcek P, Bendlová B.
    J Pediatr Surg; 2005 Jun; 40(6):e1-6. PubMed ID: 15991157
    [Abstract] [Full Text] [Related]

  • 22. The RET proto-oncogene and cancer.
    Donis-Keller H.
    J Intern Med; 1995 Oct; 238(4):319-25. PubMed ID: 7595167
    [Abstract] [Full Text] [Related]

  • 23. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome).
    Oishi S, Sato T, Takiguchi-Shirahama S, Nakamura Y.
    Endocr J; 1995 Aug; 42(4):527-36. PubMed ID: 8556060
    [Abstract] [Full Text] [Related]

  • 24. Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.
    Engelmann D, Koczan D, Ricken P, Rimpler U, Pahnke J, Li Z, Pützer BM.
    Endocr Relat Cancer; 2009 Mar; 16(1):211-24. PubMed ID: 18984779
    [Abstract] [Full Text] [Related]

  • 25. RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma.
    Jhiang SM, Fithian L, Weghorst CM, Clark OH, Falko JM, O'Dorisio TM, Mazzaferri EL.
    Thyroid; 1996 Apr; 6(2):115-21. PubMed ID: 8733882
    [Abstract] [Full Text] [Related]

  • 26. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
    Berndt I, Reuter M, Saller B, Frank-Raue K, Groth P, Grussendorf M, Raue F, Ritter MM, Höppner W.
    J Clin Endocrinol Metab; 1998 Mar; 83(3):770-4. PubMed ID: 9506724
    [Abstract] [Full Text] [Related]

  • 27. High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece.
    Sarika HL, Papathoma A, Garofalaki M, Vasileiou V, Vlassopoulou B, Anastasiou E, Alevizaki M.
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):857-62. PubMed ID: 22676047
    [Abstract] [Full Text] [Related]

  • 28. A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma.
    Hofstra RM, Fattoruso O, Quadro L, Wu Y, Libroia A, Verga U, Colantuoni V, Buys CH.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4176-8. PubMed ID: 9398735
    [Abstract] [Full Text] [Related]

  • 29. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 "Janus" genetic variation.
    Moore SW, Zaahl M.
    J Pediatr Surg; 2010 Feb; 45(2):393-6. PubMed ID: 20152359
    [Abstract] [Full Text] [Related]

  • 30. Novel point mutation in exon 10 of the RET proto-oncogene in a family with medullary thyroid carcinoma.
    Oriola J, Páramo C, Halperin I, García-Mayor RV, Rivera-Fillat F.
    Am J Med Genet; 1998 Jul 07; 78(3):271-3. PubMed ID: 9677065
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. RET proto-oncogene mutations in French MEN 2A and FMTC families.
    Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir GM.
    Hum Mol Genet; 1994 Nov 07; 3(11):1939-43. PubMed ID: 7874109
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Description of the first two seemingly unrelated Greek Cypriot families with a common C618R RET proto-oncogene mutation.
    Neocleous V, Passalaris T, Spanou E, Kitsios P, Skordis N, Deltas CC.
    Genet Test; 2004 Nov 07; 8(2):163-8. PubMed ID: 15345114
    [Abstract] [Full Text] [Related]

  • 37. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
    Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA.
    Hum Mol Genet; 1993 Jul 07; 2(7):851-6. PubMed ID: 8103403
    [Abstract] [Full Text] [Related]

  • 38. Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis.
    Peacock ML, Borst MJ, Sweet JD, Decker RA.
    Hum Mutat; 1996 Jul 07; 7(2):100-4. PubMed ID: 8829625
    [Abstract] [Full Text] [Related]

  • 39. Genetic aspects of familial thyroid cancer.
    Morrison PJ, Atkinson AB.
    Oncologist; 2009 Jun 07; 14(6):571-7. PubMed ID: 19465682
    [Abstract] [Full Text] [Related]

  • 40. Mutations in the cysteine-rich region of the RET proto-oncogene in patients diagnosed as having sporadic medullary thyroid carcinoma.
    Kimura T, Yoshimoto K, Yokogoshi Y, Saito S.
    Endocr J; 1995 Aug 07; 42(4):517-25. PubMed ID: 8556059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.